WHO says remde­sivir has lit­tle ef­fect in hos­pi­tal­ized Covid-19 — but Gilead calls new da­ta 'in­con­sis­ten­t' with pre­vi­ous find­ings

A new WHO study is throw­ing cold wa­ter on the ef­fec­tive­ness on remde­sivir in Covid-19 pa­tients.

Af­ter con­duct­ing a large clin­i­cal tri­al look­ing in­to remde­sivir and three oth­er treat­ments, the WHO has found that none had any sub­stan­tial ef­fect on im­prov­ing mor­tal­i­ty rates, re­duc­ing the amount of pa­tients need­ing ven­ti­la­tors or short­en­ing hos­pi­tal stays. The oth­er ther­a­pies in the study were hy­drox­y­chloro­quine, lopinavir and in­ter­fer­on.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.